Matches in UGent Biblio for { <https://biblio.ugent.be/publication/2153315#aggregation> ?p ?o. }
Showing items 1 to 42 of
42
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B433905.
- aggregation creator B433906.
- aggregation creator B433907.
- aggregation creator B433908.
- aggregation creator B433909.
- aggregation creator B433910.
- aggregation creator B433911.
- aggregation creator B433912.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 2153315.bibtex.
- aggregation hasFormat 2153315.csv.
- aggregation hasFormat 2153315.dc.
- aggregation hasFormat 2153315.didl.
- aggregation hasFormat 2153315.doc.
- aggregation hasFormat 2153315.json.
- aggregation hasFormat 2153315.mets.
- aggregation hasFormat 2153315.mods.
- aggregation hasFormat 2153315.rdf.
- aggregation hasFormat 2153315.ris.
- aggregation hasFormat 2153315.txt.
- aggregation hasFormat 2153315.xls.
- aggregation hasFormat 2153315.yaml.
- aggregation isPartOf urn:issn:0887-6924.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Biology and Life Sciences".
- aggregation title "RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis".
- aggregation abstract "Evasion of apoptosis may contribute to poor treatment response in pediatric acute lymphoblastic leukemia (ALL), calling for novel treatment strategies. Here, we report that inhibitors of apoptosis (IAPs) at subtoxic concentrations cooperate with various anticancer drugs (that is, AraC, Gemcitabine, Cyclophosphamide, Doxorubicin, Etoposide, Vincristine and Taxol) to induce apoptosis in ALL cells in a synergistic manner as calculated by combination index and to reduce long-term clonogenic survival. Importantly, we identify RIP1 as a critical regulator of this synergism of IAP inhibitors and AraC that mediates the formation of a RIP1/FADD/caspase-8 complex via an autocrine/paracrine loop of tumor necrosis factor-alpha (TNF alpha). Knockdown of RIP1 abolishes formation of this complex and subsequent activation of caspase-8 and -3, mitochondrial perturbations and apoptosis. Similarly, inhibition of RIP1 kinase activity by Necrostatin-1 or blockage of TNF alpha by Enbrel inhibits IAP inhibitor-and AraC-triggered interaction of RIP1, FADD and caspase-8 and apoptosis. In contrast to malignant cells, IAP inhibitors and AraC at equimolar concentrations are non-toxic to normal peripheral blood lymphocytes or mesenchymal stromal cells. Thus, our findings provide first evidence that IAP inhibitors present a promising strategy to prime childhood ALL cells for chemotherapy-induced apoptosis in a RIP1-dependent manner. These data have important implications for developing apoptosis-targeted therapies in childhood leukemia.".
- aggregation authorList BK755744.
- aggregation endPage "1029".
- aggregation issue "5".
- aggregation startPage "1020".
- aggregation volume "26".
- aggregation aggregates 4381275.
- aggregation isDescribedBy 2153315.
- aggregation similarTo leu.2011.353.
- aggregation similarTo LU-2153315.